Isis Pharmaceuticals Inc. (ISIS) ended the first quarter, with nearly $427 million in cash. Revenue for the three months ended March 31, 2011 was $21.1 million, compared to $29.9 million for the same period in 2010.
Isis Pharmaceuticals earned a $3 million payment from GlaxoSmithKline (GSK) to discover and develop drugs to treat rare and infectious diseases. Isis have well identified our first development candidate, ISIS-TTRRx, which is ready to begin a Phase 1 clinical study. If all six programs are successfully developed, Isis is eligible to receive license fees and milestone payments, totaling nearly $1.5 billion. Isis Pharmaceuticals also has strategic alliance with Bristol-Myers Squibb (BMY), Eli Lilly (LLY) , Teva (TEVA) and many others.
In my views, GlaxoSmithKline and Isis Pharmaceuticals partnership shouldn't be overlooked as a long-term. What others have to say?
Few Biotechnology & Drugs stocks to watch: Isis Pharmaceuticals Inc. (ISIS) Industry peers and competitors-
Abbott Laboratories (ABT) is trading at a price of $53.5 , a dramatic change of -0.5 with % change of -0.93 ,the company has a Market capitalization (total value of a company in the stock market) of approximately 82.80B
AstraZeneca plc (AZN) is trading at a price of $51.49 , a dramatic change of -0.1 with % change of -0.19 ,the company has a Market capitalization (total value of a company in the stock market) of approximately 71.26B
Novo Nordisk (NVO) is trading at a price of $122.96 , a dramatic change of 0.42 with % change of 0.34,the company has a Market capitalization (total value of a company in the stock market) of approximately 60.56B
Amgen Inc. (AMGN) is trading at a price of $60.89 , a dramatic change of 1.03 with % change of 1.72 ,the company has a Market capitalization (total value of a company in the stock market) of approximately 56.61B
Bristol Myers Squibb Co. (BMY) is trading at a price of $28.65 , a dramatic change of -0.14 with % change of -0.49 ,the company has a Market capitalization (total value of a company in the stock market) of approximately 48.84B
Teva Pharmaceutical Industries Ltd (TEVA) is trading at a price of $49.63 , a dramatic change of 0.12 with % change of 0.24 ,the company has a Market capitalization (total value of a company in the stock market) of approximately 46.64B
Gilead Sciences Inc. (GILD) is trading at a price of $40.47 , a dramatic change of -0.09 with % change of -0.22 ,the company has a Market capitalization (total value of a company in the stock market) of approximately 31.85B
Celgene Corporation (CELG) is trading at a price of $60.48 , a dramatic change of 0.96 with % change of 1.61 ,the company has a Market capitalization (total value of a company in the stock market) of approximately 27.99B
Allergan Inc. (AGN) is trading at a price of $81.54 , a dramatic change of -0.31 with % change of -0.38 ,the company has a Market capitalization (total value of a company in the stock market) of approximately 25.07B
Biogen Idec Inc. (BIIB) is trading at a price of $97.57 , a dramatic change of 1.43 with % change of 1.49 ,the company has a Market capitalization (total value of a company in the stock market) of approximately 23.58B
Shire Plc. (SHPGY) is trading at a price of $93.36 , a dramatic change of -0.42 with % change of -0.45 ,the company has a Market capitalization (total value of a company in the stock market) of approximately 17.50B
Cardinal Health Inc. (CAH) is trading at a price of $44.78 , a dramatic change of -0.16 with % change of -0.36 ,the company has a Market capitalization (total value of a company in the stock market) of approximately 15.70B
Valeant Pharmaceuticals Int (VRX) is trading at a price of $49.66 , a dramatic change of -0.9 with % change of -1.78 ,the company has a Market capitalization (total value of a company in the stock market) of approximately 14.80B
Vertex Pharmaceuticals Incorporated (VRTX) is trading at a price of $56.51 , a dramatic change of -0.76 with % change of -1.33 ,the company has a Market capitalization (total value of a company in the stock market) of approximately 11.64B
AmerisourceBergen Corp. (ABC) is trading at a price of $42.04 , a dramatic change of -0.23 with % change of -0.54 ,the company has a Market capitalization (total value of a company in the stock market) of approximately 11.52B
Forest Laboratories Inc. (FRX) is trading at a price of $34.47 , a dramatic change of 0.02 with % change of 0.06 ,the company has a Market capitalization (total value of a company in the stock market) of approximately 9.86B
Life Technologies Corp. (LIFE) is trading at a price of $54 , a dramatic change of -1.62 with % change of -2.91 ,the company has a Market capitalization (total value of a company in the stock market) of approximately 9.65B
Hospira Inc. (HSP) is trading at a price of $54.58 , a dramatic change of -0.39 with % change of -0.71 ,the company has a Market capitalization (total value of a company in the stock market) of approximately 9.16B
Alexion Pharmaceuticals Inc. (ALXN) is trading at a price of $97.19 , a dramatic change of 0.87 with % change of 0.9 ,the company has a Market capitalization (total value of a company in the stock market) of approximately 8.93B
Perrigo Company (PRGO) is trading at a price of $85.1 , a dramatic change of -0.55 with % change of -0.64 ,the company has a Market capitalization (total value of a company in the stock market) of approximately 7.89B
CEOWORLD Magazine is looking for talented editorial interns…
SPECIAL DISCOUNT- SUBSCRIBE to CEOWORLD Magazine Digital Magazine & SAVE UP TO 80% OFF. Reaching more than 85,000Chief Executive Officers and decision making executives who serve on the boards of leading companies. SUBSCRIBE NOW!!!
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
